Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.5800
+0.00981.72%
Post-market: 0.58000.00000.00%19:34 EDT
Volume:12.28K
Turnover:7.12K
Market Cap:3.37M
PE:-0.23
High:0.5872
Open:0.5702
Low:0.5702
Close:0.5702
Loading ...
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 02, 2023

Correspondence

Form CORRESP - Correspondence
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 07, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Correspondence

Form CORRESP - Correspondence
Jun 06, 2023

Correspondence

Form CORRESP - Correspondence
May 31, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 31, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 18, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]